Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in pregnant women with PCOS
NCT00159536Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Feb 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS), sponsored by Norwegian University of Science and Technology. Primary endpoints: Gestational diabetes and Incidence of metabolic syndrome and neurophysiologic parameters in offspring at 18 years. Started Feb 2005; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00159536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159536.